AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 165 filers reported holding AKERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $304,416 | -73.1% | 25,200 | 0.0% | 0.02% | -72.9% |
| Q2 2023 | $1,133,244 | -4.3% | 25,200 | -4.3% | 0.06% | -14.5% |
| Q1 2023 | $1,184,516 | +0.4% | 26,346 | +1.4% | 0.07% | -4.2% |
| Q4 2022 | $1,179,868 | +2.3% | 25,994 | -13.9% | 0.07% | -12.2% |
| Q3 2022 | $1,153,000 | +273.1% | 30,200 | 0.0% | 0.08% | +272.7% |
| Q2 2022 | $309,000 | +17.0% | 30,200 | 0.0% | 0.02% | +10.0% |
| Q1 2022 | $264,000 | -51.8% | 30,200 | 0.0% | 0.02% | -48.7% |
| Q4 2021 | $548,000 | -26.8% | 30,200 | 0.0% | 0.04% | -26.4% |
| Q3 2021 | $749,000 | -43.0% | 30,200 | -50.0% | 0.05% | +8.2% |
| Q2 2021 | $1,314,000 | +44.1% | 60,400 | +100.0% | 0.05% | -34.7% |
| Q1 2021 | $912,000 | -2.8% | 30,200 | 0.0% | 0.08% | -15.7% |
| Q4 2020 | $938,000 | +12.6% | 30,200 | 0.0% | 0.09% | -10.1% |
| Q3 2020 | $833,000 | -27.6% | 30,200 | 0.0% | 0.10% | -31.2% |
| Q2 2020 | $1,150,000 | +85.2% | 30,200 | 0.0% | 0.14% | +50.0% |
| Q1 2020 | $621,000 | +4.4% | 30,200 | 0.0% | 0.10% | +31.5% |
| Q4 2019 | $595,000 | -6.4% | 30,200 | 0.0% | 0.07% | -18.9% |
| Q3 2019 | $636,000 | -5.9% | 30,200 | 0.0% | 0.09% | -7.2% |
| Q2 2019 | $676,000 | – | 30,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $169,134,000 | 18.83% |
| venBio Partners LLC | 2,444,311 | $70,909,000 | 6.74% |
| Versant Venture Management, LLC | 617,727 | $17,920,000 | 3.49% |
| Redmile Group, LLC | 2,513,746 | $72,924,000 | 1.03% |
| Boxer Capital, LLC | 831,495 | $24,122,000 | 0.82% |
| Integral Health Asset Management, LLC | 85,000 | $2,466,000 | 0.70% |
| Vivo Capital, LLC | 673,280 | $19,532,000 | 0.69% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 32,000 | $928,000 | 0.51% |
| Cormorant Asset Management, LP | 742,549 | $21,541,000 | 0.48% |
| HHLR ADVISORS, LTD. | 1,656,673 | $48,060,000 | 0.48% |